Page 68 | Certara

White Paper

PBPK modeling for predicting drug-drug interactions (DDI)

Inform and replace costly drug-drug interaction (DDI) studies with PBPK modeling. Explore 13 real-world examples…

CertaraMarch 25, 2024

Conference

RAPS Euro Convergence 2024

CertaraMarch 25, 2024

Press Coverage

Hallmarks of neurodegenerative disease: A systems pharmacology perspective

Authors: Peter Bloomingdale, Tatiana Karelina, Vidya Ramakrishnan, Suruchi Bakshi, Florence Véronneau-Veilleux, Matthew Moye, Kazutaka Sekiguchi,…

CertaraMarch 22, 2024

Blog

How Drug Discovery Tools Aid Pharma Decision-Making

Learn how drug discovery tools can help pharmaceutical industry professionals make more informed decisions based…

CertaraMarch 22, 2024

White Paper

FDA SEND Dataset Requirements for Nonclinical Studies

This white paper is a step-by-step guide for submitting datasets in the SEND format.

CertaraMarch 21, 2024

On-Demand Webinar

The State of AI in In Silico Trials and Drug Development – The Practical Application of AI in QSP [APAC Webinar]

The proliferation of AI models and GPTs has revolutionized how the life sciences industry consumes…

CertaraMarch 20, 2024

Blog

Why Medical/Regulatory Writing Services Use Style Guides & Lexicons

Learn how style guides and lexicons help medical writers produce clear, consistent, and accurate content…

CertaraMarch 18, 2024

On-Demand Webinar

Dual Filing Strategies: How to Jointly Publish Marketing Applications for EMA and FDA

Even if the product is the same, the applications for marketing authorization in Europe and…

CertaraMarch 15, 2024

On-Demand Webinar

Adding Quality Control & Validation to Drug Discovery with AI

The proliferation of powerful AI models, including GPTs, has revolutionized how the life sciences industry…

CertaraMarch 14, 2024

Blog

How Clinical Trial Software Helps Make Studies More Efficient

March 13, 2024 Clinical trials play a crucial role in advancing medical research and improving…

CertaraMarch 13, 2024

PBPK modeling for predicting drug-drug interactions (DDI)

RAPS Euro Convergence 2024

Hallmarks of neurodegenerative disease: A systems pharmacology perspective

How Drug Discovery Tools Aid Pharma Decision-Making

FDA SEND Dataset Requirements for Nonclinical Studies

The State of AI in In Silico Trials and Drug Development – The Practical Application of AI in QSP [APAC Webinar]

Why Medical/Regulatory Writing Services Use Style Guides & Lexicons

Dual Filing Strategies: How to Jointly Publish Marketing Applications for EMA and FDA

Adding Quality Control & Validation to Drug Discovery with AI

How Clinical Trial Software Helps Make Studies More Efficient

Newsletter sign up

Quick links

Solutions

Contact